Chaoju Eye Care Holdings Past Earnings Performance
Past criteria checks 3/6
Chaoju Eye Care Holdings has been growing earnings at an average annual rate of 23.3%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been growing at an average rate of 12.9% per year. Chaoju Eye Care Holdings's return on equity is 9.3%, and it has net margins of 16.7%.
Key information
23.3%
Earnings growth rate
9.4%
EPS growth rate
Healthcare Industry Growth | 11.3% |
Revenue growth rate | 12.9% |
Return on equity | 9.3% |
Net Margin | 16.7% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Chaoju Eye Care Holdings' (HKG:2219) Upcoming Dividend Will Be Larger Than Last Year's
Jun 09Chaoju Eye Care Holdings (HKG:2219) Will Pay A Larger Dividend Than Last Year At CN¥0.2975
Apr 24Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Have Been Accounted For Conservatively
Apr 02Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year
Apr 01An Intrinsic Calculation For Chaoju Eye Care Holdings Limited (HKG:2219) Suggests It's 20% Undervalued
Jul 10Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year
Jun 07Earnings Report: Chaoju Eye Care Holdings Limited Missed Revenue Estimates By 7.9%
Mar 31A Look At The Fair Value Of Chaoju Eye Care Holdings Limited (HKG:2219)
Feb 28Chaoju Eye Care Holdings (HKG:2219) Could Be Struggling To Allocate Capital
Feb 06Chaoju Eye Care Holdings (HKG:2219) Is Reinvesting At Lower Rates Of Return
Aug 31We Think Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Are Understated
Apr 04Revenue & Expenses Breakdown
How Chaoju Eye Care Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 1,370 | 229 | 332 | 0 |
30 Sep 23 | 1,260 | 232 | 298 | 0 |
30 Jun 23 | 1,150 | 235 | 265 | 0 |
31 Mar 23 | 1,070 | 211 | 244 | 0 |
31 Dec 22 | 990 | 188 | 223 | 0 |
30 Sep 22 | 1,010 | 186 | 227 | 0 |
30 Jun 22 | 1,030 | 184 | 231 | 0 |
31 Mar 22 | 1,014 | 173 | 220 | 0 |
31 Dec 21 | 998 | 162 | 209 | 0 |
30 Sep 21 | 986 | 163 | 201 | 0 |
30 Jun 21 | 975 | 164 | 194 | 0 |
31 Mar 21 | 885 | 144 | 181 | 0 |
31 Dec 20 | 794 | 124 | 168 | 0 |
31 Dec 19 | 715 | 76 | 153 | 0 |
31 Dec 18 | 633 | 39 | 165 | 0 |
Quality Earnings: 2219 has high quality earnings.
Growing Profit Margin: 2219's current net profit margins (16.7%) are lower than last year (19%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2219's earnings have grown significantly by 23.3% per year over the past 5 years.
Accelerating Growth: 2219's earnings growth over the past year (21.9%) is below its 5-year average (23.3% per year).
Earnings vs Industry: 2219 earnings growth over the past year (21.9%) exceeded the Healthcare industry 7.8%.
Return on Equity
High ROE: 2219's Return on Equity (9.3%) is considered low.